FinCEN will
expeditiously issue a notice and work with OIRA to review the
collection within the normal PRA process.
Inventory as of this Action
Requested
Previously Approved
10/31/2020
6 Months From Approved
23,615
0
0
47,230
0
0
0
0
0
FinCEN is issuing this final rule,
pursuant to Section 311 of the USA PATRIOT Act, to prohibit the
opening or maintaining of correspondent accounts in the United
States for, or on behalf of, Iranian financial institutions, and
the use of foreign financial institutions’ correspondent accounts
at covered U.S. financial institutions to process transactions
involving Iranian financial institutions.
US Code:
31
USC 5318A Name of Law: USA PATRIOT Act Pub. L. 107-56
FinCEN is issuing a final rule
under the authority of section 5318A of Title 31, United States
Code, to impose a special measure against a Jurisdiction of Primary
Money Laundering Concern. FinCEN has determined that a jurisdiction
is of primary money laundering concern, and that the imposition of
the special measure selected ‒ restricting domestic financial
institutions from maintaining foreign correspondent accounts with a
foreign jurisdiction 31 U.S.C. 5318(b)(5) - is a necessary step to
ensure it is not able to access the U.S. financial system for
terrorist financing or money laundering, or for any other illicit
purpose.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.